We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.08B
AUM Growth
+$407M
Cap. Flow
+$226M
Cap. Flow %
4.45%
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$69.6M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$63M
3
MDB icon
MongoDB
MDB
+$59.3M
4
DV icon
DoubleVerify
DV
+$47.6M
5
FLYW icon
Flywire
FLYW
+$39.8M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$165M
2
DUOL icon
Duolingo
DUOL
+$33.1M
3
KURA icon
Kura Oncology
KURA
+$32.8M
4
COGT icon
Cogent Biosciences
COGT
+$30.6M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$25.8M

Sector Composition

Rank Sector Weight
1 Healthcare 38.81%
2 Technology 24%
3 Industrials 15.64%
4 Consumer Discretionary 5.21%
5 Utilities 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRLN
126
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$4.09M 0.08%
396,667
– –
KALV
127
DELISTED
KalVista Pharmaceuticals
KALV
$4.01M 0.08%
+276,200
New +$3.86M
SHW icon
128
Sherwin-Williams
SHW
$83.7B
$3.83M 0.08%
18,692
+192
+1% +$45.5K
PHVS icon
129
Pharvaris
PHVS
$2.37B
$3.62M 0.07%
450,251
– –
EQT icon
130
EQT Corp
EQT
$33B
$3.34M 0.07%
+81,934
New +$3.55M
EPIX
131
DELISTED
ESSA Pharma
EPIX
$2.84M 0.06%
1,561,251
-1,804,317
-54% -$4.75M
AIP icon
132
Arteris
AIP
$1.35B
$2.64M 0.05%
396,021
+197,512
+99% +$1.52M
CMPX icon
133
Compass Therapeutics
CMPX
$349M
$2.51M 0.05%
+1,100,399
New +$3.05M
TRGP icon
134
Targa Resources
TRGP
$57.6B
$2.18M 0.04%
36,200
-69,822
-66% -$4.59M
BILL icon
135
BILL Holdings
BILL
$4.52B
$1.66M 0.03%
+12,500
New +$1.8M
WMS icon
136
Advanced Drainage Systems
WMS
$10.5B
$1.09M 0.02%
8,752
-31,300
-78% -$3.9M
PLD icon
137
Prologis
PLD
$136B
$1.06M 0.02%
10,400
-39,113
-79% -$4.85M
CGNX icon
138
Cognex
CGNX
$10.4B
– –
-359,000
Closed -$15.3M
CIEN icon
139
Ciena
CIEN
$52.7B
– –
-32,000
Closed -$1.46M
DSGN icon
140
Design Therapeutics
DSGN
$788M
– –
-281,569
Closed -$3.94M
DUOL icon
141
Duolingo
DUOL
$6.22B
– –
-378,375
Closed -$33.1M
GRMN
142
Garmin
GRMN
$57.4B
– –
-55,700
Closed -$5.47M
KBH icon
143
KB Home
KBH
$3.45B
– –
-35,100
Closed -$999K
KURA icon
144
Kura Oncology
KURA
$826M
– –
-1,790,144
Closed -$32.8M
LOB icon
145
Live Oak Bancshares
LOB
$1.97B
– –
-136,983
Closed -$4.64M
MNDY icon
146
monday.com
MNDY
$3.73B
– –
-20,409
Closed -$2.1M
NRIX icon
147
Nurix Therapeutics
NRIX
$2.45B
– –
-1,154,000
Closed -$14.6M
PHAT icon
148
Phathom Pharmaceuticals
PHAT
$731M
– –
-336,223
Closed -$2.84M
SLAB icon
149
Silicon Laboratories
SLAB
$7.15B
– –
-19,137
Closed -$2.68M
VITL icon
150
Vital Farms
VITL
$536M
– –
-950,092
Closed -$8.31M
3 4 5
6
7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Eventide Asset Management held 154 positions worth $5.08B, up 8.7% from $4.68B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $226M of net new capital in Q3 2022, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was DoubleVerify: 1,847,144 shares worth $50.5M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Cogent Biosciences, an estimated $30.6M trimmed.

  • Eventide Asset Management's largest Q3 2022 buy was DoubleVerify: 1,847,144 shares worth $50.5M.
  • Eventide Asset Management added most to Doximity in Q3 2022, an estimated $69.6M increase.
  • Eventide Asset Management's biggest Q3 2022 reduction was Cogent Biosciences, cutting an estimated $30.6M.
  • Eventide Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $5.08B portfolio in Q3 2022.
  • Eventide Asset Management opened 18 new positions and closed 16 in Q3 2022.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $5.08B.

Based on Eventide Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.